Open-Heart Surgery and Technology - Cardiovascular Update

Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System

DAIC

JANUARY 6, 2025

6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).

Pulmonary

Pulmonary Congenital Heart Disease Open-Heart Surgery Congenital

Cryoanalgesia: Innovative Freezing Technology for Sternotomy Pain

CTVS

MARCH 31, 2025

It is a serious surgery that opens up the chest cavity through the breastbone, or sternum, to gain access to the lungs and heart. A sternotomy procedure is done in advance of other procedures like coronary artery bypass surgery, aortic valve repair and replacement, VAD (ventricular assist device) implantation… Source

Innovation

Innovation Technology Aortic valve Aortic

Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery

DAIC

JUNE 10, 2024

milla1cf Mon, 06/10/2024 - 17:58 June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center. The recent approval of the tricuspid clip device by the U.S.

Heart Valves

Heart Valves Tricuspid Open-Heart Surgery Quality of Life

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Fujifilm Introduces First-of-its-Kind Transducer for On-Pump Intracardiac Echocardiography Imaging (OPIE) for Septal Myectomy

DAIC

APRIL 29, 2024

Early clinical users of the OPIE transducer will discuss how the technology helps to evaluate the ventricular septal thickness during septal myectomy surgery by providing real-time imaging visualization during the 104th American Association for Thoracic Surgery ( AATS ) meeting held April 27-30 in Toronto, ON, Canada.

Cardiothoracic

Cardiothoracic Open-Heart Surgery Ultrasound Technology

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

DAIC

FEBRUARY 21, 2024

This is really the first valve that can be delivered via catheter where previously open-heart surgery was the only option for patients healthy enough to undergo the procedure,” said Brian O’Neill, M.D. director of Interventional and Structural Heart Research at Henry Ford Hospital. William O’Neill, M.D.

Heart Failure

Heart Failure Open-Heart Surgery Tricuspid Heart Disease

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

DAIC

JUNE 3, 2024

Food and Drug Administration ( FDA ) granted an Investigational Device Exemption (IDE) to initiate a US Pivotal Study with its technology. Over 100 patients have been treated with the HighLife technology within different clinical programs in the USA, Europe and APAC. Javits Convention Center, North.

Bicuspid/Mitral

Bicuspid/Mitral Technology Open-Heart Surgery Innovation

MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

DAIC

DECEMBER 26, 2023

reported results from a clinical study of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography to Detects Aortic Stenosis Murmur Before and After Transcatheter Aortic Valve Replacement (TAVR). milla1cf Tue, 12/26/2023 - 21:36 December 26, 2023 — MindMics, Inc.

Stenosis

Stenosis Technology Aortic Aortic valve

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

APRIL 2, 2024

Sorajja added, "With TriClip, physicians can offer patients a therapy option backed by excellent safety and effectiveness to help restore tricuspid native valve performance without subjecting them to high-risk open-heart surgery that may not be feasible for individuals with TR who are generally older and sicker."

Tricuspid

Tricuspid Heart Valves Quality of Life Open-Heart Surgery

Documentary Led by HonorHealth Research Institute Focuses on Injuries to Doctors and Nurses Working in Cardiology

DAIC

MAY 7, 2024

narrates and is a co-producer of a documentary focused on radiation and orthopedic injuries suffered by doctors and nurses who work in cardiac catheterization laboratories where they apply the very latest non-surgical technologies to treat the world’s leading cause of death, heart disease. Rizik , M.D.,

Nursing

Nursing Research Catheterization Laboratory Open-Heart Surgery

8 Benefits Of Minimally Invasive Cardiac Surgery

MIBHS

SEPTEMBER 15, 2023

Among these innovations, minimally invasive cardiac surgery stands out as a game-changer, offering numerous benefits over traditional open-heart surgery. Dr. Ciuffo is an expert in high-risk heart surgery cases. This reduced risk enhances the overall safety profile of these procedures.

Open-Heart Surgery

Open-Heart Surgery Coronary Artery Bypass Graft Cardiovascular Disease Innovation

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

FEBRUARY 15, 2024

"Tricuspid regurgitation can put added strain on the heart and lead to other cardiovascular issues, which can significantly worsen a person's quality of life, but historically there have been few treatment options," said Lars Søndergaard , M.D.,

Tricuspid

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral

Unlocking the Potential of TAVI: ADN CoE's Recent Masterclass Triumph

ADN Center of Excellence

NOVEMBER 6, 2023

The field of cardiology is constantly changing, with new techniques and technologies emerging to enhance care. One such innovation is the Transcatheter Aortic Valve Implantation (TAVI) which has the potential to revolutionize the treatment of valve disease by offering an invasive option compared to traditional open heart surgery.

Aortic valve

Aortic valve Open-Heart Surgery Interventional Cardiology Education

Unlocking the Potential of TAVI: ADN CoE's Recent Masterclass Triumph

ADN Center of Excellence

NOVEMBER 6, 2023

The field of cardiology is constantly changing, with new techniques and technologies emerging to enhance care. One such innovation is the Transcatheter Aortic Valve Implantation (TAVI) which has the potential to revolutionize the treatment of valve disease by offering an invasive option compared to traditional open heart surgery.

Aortic valve

Aortic valve Open-Heart Surgery Interventional Cardiology Education

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices

Cardiometabolic Health Congress

JULY 17, 2024

Edwards EVOQUE Tricuspid Valve Replacement System (Approved: 02/01/2024) This system provides a novel approach to tricuspid valve replacement, potentially benefiting patients with tricuspid regurgitation without open-heart surgery. March 2024 FDA Approvals: A Milestone Month for Cardiorenal metabolic Health 1.

Tricuspid

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics

Brachiocephalic Artery Access for Transcatheter Aortic Valve Replacement

All About Cardiovascular System and Disorders

MAY 19, 2024

It does not involve open heart surgery which is otherwise needed for surgical aortic valve replacement. Brachiocephalic artery access without sternotomy for TAVR has been described as a Cutting-Edge Technology in a paper which has been just accepted in the JACC Asia [1].

Aortic valve

Aortic valve Aortic TAVR Open-Heart Surgery

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

DAIC

MARCH 12, 2024

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. At Medtronic, we continue to emphasize that valve design matters.

TAVR

TAVR Aortic valve Aortic Stenosis

Topical Tranexamic Acid Found Inferior to Intravenous Administration

DAIC

APRIL 9, 2024

The trial, called DEPOSITION, intended to enroll 3,800 patients but stopped after enrolling 3,224 patients undergoing heart surgery at 16 sites in six countries. I think there is a message that is much broader than just cardiac surgery, in that we have to look at this drug with new eyes and new technologies to improve its performance.”

Open-Heart Surgery

Open-Heart Surgery Research Technology Circulation

The Nation’s Heart: Ghana

Global Cardiac Surgery

AUGUST 14, 2018

In addition, the Center has been able to withstand the widely perceived “brain drain” in other sectors, through ensuring opportunities for surgeons to academically advance, conduct research, integrate new technology in practice, and sustain international collaborations.

Cardiothoracic

Cardiothoracic Open-Heart Surgery Bicuspid/Mitral Congenital Heart Disease

Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System

Cryoanalgesia: Innovative Freezing Technology for Sternotomy Pain

Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery

Webinars

Fujifilm Introduces First-of-its-Kind Transducer for On-Pump Intracardiac Echocardiography Imaging (OPIE) for Septal Myectomy

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

Documentary Led by HonorHealth Research Institute Focuses on Injuries to Doctors and Nurses Working in Cardiology

8 Benefits Of Minimally Invasive Cardiac Surgery

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

Unlocking the Potential of TAVI: ADN CoE's Recent Masterclass Triumph

Unlocking the Potential of TAVI: ADN CoE's Recent Masterclass Triumph

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices

Brachiocephalic Artery Access for Transcatheter Aortic Valve Replacement

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

Topical Tranexamic Acid Found Inferior to Intravenous Administration

The Nation’s Heart: Ghana

Stay Connected